Updated on 26 May 2026
Open for collaborations to advance brain regenerative medicine
Cofounder and CEO at AzureCell SA
Geneva, Switzerland
About
AzureCell is a Swiss cell therapy company born from two decades of pioneering neuroscience and cell-engineering research at the University of Geneva, the Geneva University Hospitals, and the Geneva Foundation for Medical Research.
We are scientists and innovators united by a shared belief: longevity is not just living longer, but living fully. To live fully, we must defeat neurodegenerative brain diseases that still have no cure and deprive millions of their independence, identity and quality of life.
We believe that a fearless future free from neurodegenerative disease is within reach, and we are unlocking this future by pioneering the next-generation of regenerative cell therapies for the brain.
In case of interest for a joint collaboration or research project, please reach out!
Similar opportunities
Project cooperation
Metabolomic biomarker discovery for early disease diagnosis
- Expertise offered
- Advanced diagnostics and data technologies
Paula Rodrigo
Innovation manager at IDM - Universitat de València at Instituto Interuniversitario de Reconocimiento Molecular y Desarrollo Tecnológico (IDM)
València, Spain
Project cooperation
Ecosystem integration to improve access to rare disease therapy
- Project idea is seeking partners
- Ideation - identifying the project idea
- Next-generation therapeutics and modalities
- Advanced biomanufacturing and ecosystem enablers
Mathurin Dorel
Chief Scientific Officer at TychoBio France
Paris, France
Project cooperation
- Completing the consortia
- Project idea is seeking partners
- Next-generation therapeutics and modalities
- Advanced biomanufacturing and ecosystem enablers
Zied Souguir
CEO at OctoCells
Rouen, France